Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, D-38124, Braunschweig, Germany.
Microb Biotechnol. 2017 Sep;10(5):1036-1040. doi: 10.1111/1751-7915.12835. Epub 2017 Aug 15.
Vaccines represent a cornerstone to ensure healthy lives and promote well-being for all at all ages. However, there are many diseases for which vaccines are not available, are relatively ineffective or need to be adapted periodically. Advances in microbial biotechnology will contribute to overcoming these roadblocks by laying the groundwork for improving and creating new approaches for developing better vaccines, as illustrated here in the case of influenza.
疫苗是确保所有人在所有年龄段都能健康生活和促进健康的基石。然而，仍有许多疾病尚无疫苗可用，或者疫苗相对低效，或者需要定期进行调整。微生物生物技术的进步将有助于克服这些障碍，为改进和创造新方法开发更好的疫苗奠定基础，正如这里流感案例所展示的那样。
